Review paper
Last Chance Therapies and Managed Care: Pluralism, Fair Procedures, and Legitimacy
Abstract
How can health plans make fair determinations about when "experimental" (and costly) treatments such as high dose chemotherapy with autologous bone marrow transplantation should be covered despite lack of clear clinical consensus about their benefits? Different models for managing "last chance" therapies evolving in some health plans offer promising examples of how issues of fairness and legitimacy in decision-making can be...
Paper Details
Title
Last Chance Therapies and Managed Care: Pluralism, Fair Procedures, and Legitimacy
Published Date
Mar 1, 1998
Journal
Volume
28
Issue
2
Pages
27 - 27
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History